Sleep Aids (Pharmacies) - Americas

  • Americas
  • Revenue in the Sleep Aids market is projected to reach US$1.63bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 2.12%, resulting in a market volume of US$1.81bn by 2029.
  • In global comparison, most revenue will be generated in the United States (US$1,473.00m in 2024).
  • In relation to total population figures, per person revenues of US$1.61 are generated in 2024.

Key regions: United States, Germany, Australia, India, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Sleep Aids (Pharmacies) market in Americas is experiencing significant growth and development.

Customer preferences:
Customers in the Americas are increasingly seeking sleep aids to address their sleep-related issues. Factors such as high stress levels, busy lifestyles, and the prevalence of technology are leading to sleep disturbances among the population. As a result, there is a growing demand for sleep aids that can help individuals achieve a better quality of sleep and improve their overall well-being.

Trends in the market:
One of the key trends in the Sleep Aids (Pharmacies) market in Americas is the rising popularity of natural and herbal sleep aids. Customers are becoming more conscious of the potential side effects of traditional sleep aids and are seeking alternative options. Natural sleep aids, such as herbal supplements and aromatherapy products, are gaining traction as they are perceived to be safer and have fewer side effects. Another trend in the market is the increasing availability of sleep aids in pharmacies. Pharmacies are expanding their product offerings to cater to the growing demand for sleep aids. They are stocking a wide range of products, including over-the-counter sleep aids, prescription medications, and natural remedies. This increased availability is making it more convenient for customers to access sleep aids and is driving market growth.

Local special circumstances:
In the Americas, there are certain local special circumstances that are influencing the Sleep Aids (Pharmacies) market. One of these is the prevalence of shift work and irregular working hours. Many individuals in the Americas work in industries such as healthcare, transportation, and hospitality, which require them to work during non-traditional hours. This disrupts their sleep patterns and increases the need for sleep aids to help them adjust to irregular sleep schedules. Another local special circumstance is the aging population in the Americas. As the population ages, the incidence of sleep disorders such as insomnia and sleep apnea increases. This has led to a greater demand for sleep aids among older individuals who are seeking solutions to their sleep problems.

Underlying macroeconomic factors:
Several underlying macroeconomic factors are driving the growth of the Sleep Aids (Pharmacies) market in Americas. One of these is the overall economic development in the region. As countries in the Americas experience economic growth, individuals have more disposable income to spend on healthcare products, including sleep aids. This increased purchasing power is fueling market growth. Another macroeconomic factor is the growing awareness of the importance of sleep in overall health and well-being. With increasing research and media coverage on the negative effects of sleep deprivation, individuals are becoming more conscious of the need to prioritize sleep. This is leading to a greater demand for sleep aids as people seek solutions to improve their sleep quality. In conclusion, the Sleep Aids (Pharmacies) market in Americas is developing due to customer preferences for sleep aids, including natural and herbal options. The market is also influenced by local special circumstances such as shift work and an aging population. Underlying macroeconomic factors, such as economic development and growing awareness of the importance of sleep, are driving market growth.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)